BioSpace News Archive

Policy

Work on COVID-19 Vaccine Distribution is “Mind-Bogglingly Complex”

The U.S. government is putting together the infrastructure for widespread distribution of a COVID-19 vaccine, if and when one is granted emergency use authorization (EUA) or full approval.

September 8, 2020
·
5 min read
·
Mark Terry
Drug Development

Dupixent Demonstrates Long-Term Efficacy and Safety in Treating Asthma Patients

Results from a Phase III open-label extension trial showed that the safety and efficacy profile observed in previous Dupixent trials were maintained for up to three years in adults and adolescents with moderate-to-severe asthma.

September 8, 2020
·
2 min read
·
Alex Keown
Policy

Biopharma Update on the Novel Coronavirus: September 9

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 9, 2020.

September 8, 2020
·
4 min read
·
BioSpace Editorial Staff
Drug Development

Corbus’ Lenabasum Fails Phase III Trial for Systemic Sclerosis

Lenabasum is an oral, small molecule that selectively binds as an agonist to the cannabinoid receptor type 2 (CB2).

September 8, 2020
·
3 min read
·
Mark Terry
Deals

Grifols to Acquire Remaining Alkahest Stock for $146 Million

The transaction, which is set to conclude in early 2021, will give Grifols access to Alkahest’s four product candidates.

September 8, 2020
·
3 min read
·
Krystle Vermes
Deals

Mylan Acquires Aspen’s European Thrombosis Portfolio for $757.3 Million

The portfolio is made up of well-established injectable coagulants sold in Europe under various brand names, including Arixtra, Fraxiparine, Mon-Embolex and Orgaran.

September 8, 2020
·
3 min read
·
Mark Terry
Business

NeuroOne’s Thin-Film Electrode Technology Offers Less Invasive Solution for Brain Surgery

For patients with epilepsy, the diagnosis and treatment process can be long, arduous, and filled with lengthy hospital stays. The medical device company NeuroOne Medical Technologies Corporation hopes to change that.

September 8, 2020
·
4 min read
·
Brianna Sleezer
BioCapital

CEOs Pledge to Stand Behind Science, Not Politics in Potential Vaccine Approval

The CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Moderna, Novavax, Pfizer, Merck and Sanofi all signed the pledge promising to ensure that any vaccine put forth by one or more of the companies meets the rigorous standards for approval.

September 8, 2020
·
3 min read
·
Alex Keown
Biotech Beach

Jaan Biotherapeutics Awarded NIH Grant to Advance Viral Delivered MicroRNA Inhibitory Cardiac Muscle Regeneration Therapy

Jaan Biotherapeutics (“JBT”), announced that it has been awarded a Small Business Innovation Research (SBIR) grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health under Award Number R43HL154884.

September 8, 2020
·
2 min read
Dementia, brain research, residential care: Seniors issues poll strongly during COVID-19 pandemicThe Yogen Früz Brain Project advances groundbreaking research on dementia and aging

The well-being of Canadian seniors is in hyperfocus amid the COVID-19 pandemic, according to a new national survey by The Baycrest Foundation

September 8, 2020
·
6 min read